Yücel DUMAN, Sibel ALTUNIŞIK TOPLU, Emine Nalan PARMAKSIZ, Ayse Belin ÖZER, Cemal FIRAT, Yasemin ERSOY

The role of procalcitonin and C-reactive protein in predicting candidemia in reanimation intensive care unit and burn unit patients

Aim: Predicting the diagnosis of candidemia remains a challenge for physicians. It is difficult to distinguish candidemia from other potential conditions, especially in patients under intensive care. Although blood culture is the gold standard in diagnosis, there is continued search for other markers that may be used for early prediction.This study intended to assess if procalcitonin (PCT) and C-reactive protein (CRP) may be able to guide the course of Candidemia.Materials and Methods: The study included patients over the age of 18 admitted to the Reanimation Intensive Care Unit and Burn Unit between June 2018 and June 2019 whose blood cultures exhibited growth of Candida species (spp.). Moreover, the patients’ blood cultures were also tested for Gram negative and Grow positive bacterial growth that may accompany Candida species (spp.). For all patients, we recorded the PCT and CRP values three times.Results: This study examined sixty-six patients exhibiting growth of Candida spp. in their blood cultures; 42 (64%) cases had no accompanying bacterial growth in their culture (Group 1). In addition to the growth of Candida spp., the blood cultures showed that 16 patients also had Gram-negative bacteremia (Group 2), and eight patients had Gram-positive bacteremia (Group 3). When a cut-off value of 0.5 ng/mL was considered for all candidemia patients, the first assessments did not show a statistically significant high value (p=0.053). However, when evaluated with bacteremia, the first PCT results were higher in patients with Gram-negative bacteremia. PCT and CRP changes over time were statistically significant based on two-way repeated measures comparisons (p

PDF

___

1. Martini A, Gottin L, Menestrina N, et al. Procalcitonin levels in surgical patients at risk of candidemia. J Infect 2010;60:425-30.
2. Maruna P, Nedelkinova K, Gürlich R. Physicology and Genetics of Procalcitonin 2000;49:57-61.
3. Pepys, MB, Baltz, ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol 1983;34:141-212.
4. Yetkin F, Toplu SA. The importance of procalcitonin in early diagnosis of sepsis. Med Science 2017;6:424-6.
5. Thomas-Rüddel DO, Poidinger B, Kott M, et al. MEDUSA study group. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit Care 2018;13:128.
6. Montagna MT, Coretti C, Rella A, et al. The role of procalcitonin in neonatal intensive care unit patients with candidemia. Folia Microbiol (Praha) 2013;58:27- 31.
7. Bamba Y, Moro H, Aoki N, et al. Increased presepsin levels are associated with the severity of fungal bloodstream infections. PLoS One. 2018;13:e0206089.
8. Fu Y, Chen J, Cai B, et al. The use of PCT, CRP, IL-6 and SAA in critically ill patients for an early distinction between candidemia and Gram positive/negative bacteremia. J Infect 2012;64:438-40.
9. Cortegiani A, Misseri G, Ippolito M, et al. Procalcitonin levels in candidemia versus bacteremia: a systematicreview. Crit Care 2019;23:190.
10. Wu Q, Yang H, Kang Y. Combined assessment of ΔPCT and ΔCRP could increase the ability to differentiate candidemia from bacteremia. Crit Care 2019;23:271.